GlaxoSmithKline, Sanofi get $2.1B to fund Covid-19 vaccine under Operation Warp Speed

The companies expect to begin human testing of their experimental vaccine in September.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.